LivaNova PLC Other Operating Income (Expense), Net
LivaNova PLC (LIVN) reported Other Operating Income (Expense), Net of -$12.40 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OtherOperatingIncomeExpenseNet · last filed 2026-08-05
- LivaNova PLC other operating income (expense), net for the quarter ending 2026-06-30 was -$12.40M, a 7847.50% decline year-over-year.
- LivaNova PLC other operating income (expense), net for the quarter ending 2026-03-31 was -$15.00K.
- LivaNova PLC other operating income (expense), net for the quarter ending 2025-12-31 was -$1.71M.
- LivaNova PLC other operating income (expense), net for the quarter ending 2025-09-30 was -$3.74M.
- LivaNova PLC other operating income (expense), net for fiscal 2025 was -$5.90M.
- LivaNova PLC other operating income (expense), net for fiscal 2024 was -$33.04M.
- LivaNova PLC other operating income (expense), net for fiscal 2023 was -$37.83M.
- LivaNova PLC other operating income (expense), net for fiscal 2022 was -$29.54M.
| Period end | Other Operating Income (Expense), Net 3 month | Other Operating Income (Expense), Net 6 month | Other Operating Income (Expense), Net 9 month | Other Operating Income (Expense), Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$12.40M 10-Q · filed 2026-08-05 | -$12.41M 10-Q · filed 2026-08-05 | -$14.12M derived: sum of 3 quarters · filed 2026-08-05 | -$17.86M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$15.00K 10-Q · filed 2026-05-06 | -$1.72M derived: sum of 2 quarters · filed 2026-05-06 | -$5.47M derived: sum of 3 quarters · filed 2026-05-06 | -$5.31M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$5.45M derived: sum of 2 quarters · filed 2026-02-25 | -$5.29M derived: sum of 3 quarters · filed 2026-08-05 | -$5.90M 10-K · filed 2026-02-25 |
| 2025-09-30 | -$3.74M 10-Q · filed 2025-11-05 | -$3.58M derived: sum of 2 quarters · filed 2026-08-05 | -$4.20M 10-Q · filed 2025-11-05 | -$7.60M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $160.00K 10-Q · filed 2026-08-05 | -$452.00K 10-Q · filed 2026-08-05 | -$3.85M derived: sum of 3 quarters · filed 2026-08-05 | -$13.03M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$612.00K 10-Q · filed 2026-05-06 | -$4.01M derived: sum of 2 quarters · filed 2026-05-06 | -$13.19M derived: sum of 3 quarters · filed 2026-05-06 | -$18.04M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$3.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$12.58M derived: sum of 2 quarters · filed 2026-02-25 | -$17.43M derived: sum of 3 quarters · filed 2026-02-25 | -$33.04M 10-K · filed 2026-02-25 |
| 2024-09-30 | -$9.18M 10-Q · filed 2025-11-05 | -$14.02M derived: sum of 2 quarters · filed 2025-11-05 | -$29.64M 10-Q · filed 2025-11-05 | -$38.32M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | -$4.84M 10-Q · filed 2025-08-06 | -$20.46M 10-Q · filed 2025-08-06 | -$29.14M derived: sum of 3 quarters · filed 2026-02-25 | -$45.15M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | -$15.62M 10-Q · filed 2025-05-07 | -$24.30M derived: sum of 2 quarters · filed 2026-02-25 | -$40.31M derived: sum of 3 quarters · filed 2026-02-25 | -$51.13M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | -$8.68M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$24.69M derived: sum of 2 quarters · filed 2026-02-25 | -$35.52M derived: sum of 3 quarters · filed 2026-02-25 | -$37.83M 10-K · filed 2026-02-25 |
| 2023-09-30 | -$16.01M 10-Q · filed 2024-10-31 | -$26.84M derived: sum of 2 quarters · filed 2024-10-31 | -$29.14M 10-Q · filed 2024-10-31 | -$34.16M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | -$10.82M 10-Q · filed 2024-08-01 | -$13.13M 10-Q · filed 2024-08-01 | -$18.15M derived: sum of 3 quarters · filed 2025-02-25 | -$41.29M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | -$2.31M 10-Q · filed 2024-05-03 | -$7.33M derived: sum of 2 quarters · filed 2025-02-25 | -$30.47M derived: sum of 3 quarters · filed 2025-02-25 | -$32.35M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | -$5.02M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$28.16M derived: sum of 2 quarters · filed 2025-02-25 | -$30.04M derived: sum of 3 quarters · filed 2025-02-25 | -$29.54M 10-K · filed 2025-02-25 |
| 2022-09-30 | -$23.14M 10-Q · filed 2023-11-01 | -$25.02M derived: sum of 2 quarters · filed 2023-11-01 | -$24.52M 10-Q · filed 2023-11-01 | -$32.88M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | -$1.88M 10-Q · filed 2023-07-26 | -$1.38M 10-Q · filed 2023-07-26 | -$9.73M derived: sum of 3 quarters · filed 2024-02-29 | -$10.80M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $505.00K 10-Q · filed 2023-05-03 | -$7.85M derived: sum of 2 quarters · filed 2024-02-29 | -$8.92M derived: sum of 3 quarters · filed 2024-02-29 | -$42.16M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | -$8.36M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$9.42M derived: sum of 2 quarters · filed 2024-02-29 | -$42.66M derived: sum of 3 quarters · filed 2024-02-29 | -$51.46M 10-K · filed 2024-02-29 |
| 2021-09-30 | -$1.07M 10-Q · filed 2022-11-02 | -$34.30M derived: sum of 2 quarters · filed 2022-11-02 | -$43.10M 10-Q · filed 2022-11-02 | |
| 2021-06-30 | -$33.24M 10-Q · filed 2022-08-03 | -$42.04M 10-Q · filed 2022-08-03 | ||
| 2021-03-31 | -$8.80M 10-Q · filed 2022-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |